Nikhil C Munshi

Nikhil C Munshi

UNVERIFIED PROFILE

Are you Nikhil C Munshi?   Register this Author

Register author
Nikhil C Munshi

Nikhil C Munshi

Publications by authors named "Nikhil C Munshi"

Are you Nikhil C Munshi?   Register this Author

100Publications

2775Reads

43Profile Views

Introduction by the Guest Editor: At a Crossroad to Cure: From Molecule to Management Strategies in Multiple Myeloma.

Authors:
Nikhil C Munshi

Cancer J 2019 Jan/Feb;25(1)

From the Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, and VA Boston Healthcare System, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000357DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386173PMC
January 2020

The effects of MicroRNA deregulation on pre-RNA processing network in multiple myeloma.

Leukemia 2019 Jun 10. Epub 2019 Jun 10.

Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0498-5DOI Listing
June 2019

Non-overlapping Control of Transcriptome by Promoter- and Super-Enhancer-Associated Dependencies in Multiple Myeloma.

Cell Rep 2018 Dec;25(13):3693-3705.e6

Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; VA Boston Healthcare System, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2018.12.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407615PMC
December 2018

Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma.

Clin Lymphoma Myeloma Leuk 2018 06 15;18(6):422-430. Epub 2018 Mar 15.

State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academic Medical Science and Peking Union Medical College, Tianjin, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.03.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970050PMC
June 2018

Widespread intronic polyadenylation diversifies immune cell transcriptomes.

Nat Commun 2018 04 30;9(1):1716. Epub 2018 Apr 30.

Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-04112-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928244PMC
April 2018

Diagnosis of Castleman Disease.

Hematol Oncol Clin North Am 2018 02;32(1):53-64

Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, M230 Boston, MA 02215, USA; VA Boston Healthcare System, 1400 VFW Parkway, West Roxbury, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08898588173014
Publisher Site
http://dx.doi.org/10.1016/j.hoc.2017.09.005DOI Listing
February 2018

Castleman Disease.

Hematol Oncol Clin North Am 2018 02;32(1):xiii-xiv

Dana Farber Cancer Institute, VA Boston Healthcare System, Harvard Medical School, 450 Brookline Avenue, M230, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2017.10.001DOI Listing
February 2018

Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation.

Nat Commun 2017 11 20;8(1):1613. Epub 2017 Nov 20.

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 500 Main St., Cambridge, MA, 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-017-01593-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694762PMC
November 2017

Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma.

Clin Cancer Res 2017 Sep 25;23(17):5225-5237. Epub 2017 Apr 25.

Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-0263DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581671PMC
September 2017

Prospective Evaluation of Magnetic Resonance Imaging and [F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study.

J Clin Oncol 2017 Sep 7;35(25):2911-2918. Epub 2017 Jul 7.

Philippe Moreau, Florence Caillon, Caroline Bodet-Milin, Aurelie Gaultier, Jean-Michel Nguyen, Benoit Dupas, Eric Frampas, and Françoise Kraeber-Bodere, University Hospital, Nantes; Michel Attal, University Hospital, Toulouse; Denis Caillot, University Hospital, Dijon; Margaret Macro, University Hospital, Caen; Lionel Karlin, University Hospital, Lyon; Laurent Garderet, University Hospital Saint-Antoine, Paris; Thierry Facon, University Hospital, Lille; Lotfi Benboubker, University Hospital, Tours; Martine Escoffre-Barbe, University Hospital, Rennes; Anne-Marie Stoppa, Institut Paoli-Calmettes, Marseille; Kamel Laribi, University Hospital, Le Mans; Cyrille Hulin and Gerald Marit, University Hospital, Bordeaux; Aurore Perrot, University Hospital, Nancy; Jean-Richard Eveillard, University Hospital, Brest; Brigitte Pegourie, University Hospital, Grenoble; Veronique Dorvaux, University Hospital, Metz; Carine Chaleteix, University Hospital, Clermont-Ferrand; and Herve Avet-Loiseau, University Hospital, Toulouse, France; and Kenneth Anderson, Paul Richardson, and Nikhil C. Munshi, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.2975DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578392PMC
September 2017

Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma.

Clin Cancer Res 2017 Aug 1;23(15):4290-4300. Epub 2017 Mar 1.

LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-3192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540790PMC
August 2017

Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells.

Clin Cancer Res 2017 Aug 7;23(15):4280-4289. Epub 2017 Mar 7.

LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2692DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540781PMC
August 2017

Impact of RAD51C-mediated Homologous Recombination on Genomic Integrity in Barrett's Adenocarcinoma Cells.

J Gastroenterol Hepatol Res 2017 21;6(1):2286-2295. Epub 2017 Feb 21.

Department of Adult Oncology, Harvard (Dana Farber) Cancer Institute, Boston, MA, the United States. VA Health Care System, West Roxbury, MA, the United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.17554/j.issn.2224-3992.2017.06.687DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796564PMC
February 2017

Next-Generation Sequencing Informing Therapeutic Decisions and Personalized Approaches.

Am Soc Clin Oncol Educ Book 2016 ;35:e442-8

From the Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; VA Boston Healthcare System, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_159017DOI Listing
January 2017

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.

Authors:
Kristin A Rand Chi Song Eric Dean Daniel J Serie Karen Curtin Xin Sheng Donglei Hu Carol Ann Huff Leon Bernal-Mizrachi Michael H Tomasson Sikander Ailawadhi Seema Singhal Karen Pawlish Edward S Peters Cathryn H Bock Alex Stram David J Van Den Berg Christopher K Edlund David V Conti Todd Zimmerman Amie E Hwang Scott Huntsman John Graff Ajay Nooka Yinfei Kong Silvana L Pregja Sonja I Berndt William J Blot John Carpten Graham Casey Lisa Chu W Ryan Diver Victoria L Stevens Michael R Lieber Phyllis J Goodman Anselm J M Hennis Ann W Hsing Jayesh Mehta Rick A Kittles Suzanne Kolb Eric A Klein Cristina Leske Adam B Murphy Barbara Nemesure Christine Neslund-Dudas Sara S Strom Ravi Vij Benjamin A Rybicki Janet L Stanford Lisa B Signorello John S Witte Christine B Ambrosone Parveen Bhatti Esther M John Leslie Bernstein Wei Zheng Andrew F Olshan Jennifer J Hu Regina G Ziegler Sarah J Nyante Elisa V Bandera Brenda M Birmann Sue A Ingles Michael F Press Djordje Atanackovic Martha J Glenn Lisa A Cannon-Albright Brandt Jones Guido Tricot Thomas G Martin Shaji K Kumar Jeffrey L Wolf Sandra L Deming Halverson Nathaniel Rothman Angela R Brooks-Wilson S Vincent Rajkumar Laurence N Kolonel Stephen J Chanock Susan L Slager Richard K Severson Nalini Janakiraman Howard R Terebelo Elizabeth E Brown Anneclaire J De Roos Ann F Mohrbacher Graham A Colditz Graham G Giles John J Spinelli Brian C Chiu Nikhil C Munshi Kenneth C Anderson Joan Levy Jeffrey A Zonder Robert Z Orlowski Sagar Lonial Nicola J Camp Celine M Vachon Elad Ziv Daniel O Stram Dennis J Hazelett Christopher A Haiman Wendy Cozen

Cancer Epidemiol Biomarkers Prev 2016 12 1;25(12):1609-1618. Epub 2016 Sep 1.

Keck School of Medicine of USC and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-1193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524541PMC
December 2016

Review of siltuximab in the treatment of multicentric Castleman's disease.

Ther Adv Hematol 2016 Dec 23;7(6):360-366. Epub 2016 Jun 23.

Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620716653745DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089324PMC
December 2016

Deficiency of the immunostimulatory cytokine IL-21 promotes intestinal neoplasia via dysregulation of the Th1/Th17 axis.

Oncoimmunology 2017 7;6(1):e1261776. Epub 2016 Dec 7.

Harvard Medical School, Boston, MA, USA; Brigham and Women's Hospital, Boston, MA, USA; Surgery Services, VA Boston Healthcare System, West Roxbury, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1261776DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283644PMC
December 2016

Gene Expression Profiles in Myeloma: Ready for the Real World?

Clin Cancer Res 2016 Nov;22(22):5434-5442

Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-0867DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546147PMC
November 2016

Deep Response in Multiple Myeloma: A Critical Review.

Biomed Res Int 2015 10;2015:832049. Epub 2015 Dec 10.

Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of hematology, Hospital 12 de Octubre, Unidad CRIS, CNIO, University of Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/832049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689894PMC
October 2016

Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication.

Blood 2016 09 14;128(12):1590-603. Epub 2016 Jul 14.

LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-03-707547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034739PMC
September 2016

DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7.

Blood 2016 09 21;128(9):1214-25. Epub 2016 Jul 21.

Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-01-691618DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524533PMC
September 2016

Stromal CCR6 drives tumor growth in a murine transplantable colon cancer through recruitment of tumor-promoting macrophages.

Oncoimmunology 2016 Aug 24;5(8):e1189052. Epub 2016 May 24.

Harvard Medical School, Boston, MA, USA; Brigham and Women's Hospital, Boston, MA, USA; Surgery Service, VA Boston Healthcare System, West Roxbury, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1189052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007974PMC
August 2016

A clinically relevant in vivo zebrafish model of human multiple myeloma to study preclinical therapeutic efficacy.

Blood 2016 07 18;128(2):249-52. Epub 2016 May 18.

Medical Oncology, and LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA; VA Boston Healthcare System, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-03-704460DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946203PMC
July 2016

Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma.

Mol Cancer Ther 2016 06 18;15(6):1364-75. Epub 2016 May 18.

Department of Experimental and Clinical Medicine, Magna Graecia University and Translational Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0985DOI Listing
June 2016

Corrigendum to "Genomic heterogeneity in multiple myeloma" [Curr. Opin. Genet. Dev. 30 (2015) 56-65].

Curr Opin Genet Dev 2016 04 4;37:158. Epub 2016 Mar 4.

Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States; VA Boston Healthcare System, Boston, MA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gde.2016.02.003DOI Listing
April 2016

A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells.

Clin Cancer Res 2016 Mar 2;22(5):1222-33. Epub 2015 Nov 2.

Department of Experimental and Clinical Medicine, Magna Græcia University, Campus Salvatore Venuta, Catanzaro, Italy. Center for Biotechnology, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0489DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775414PMC
March 2016

Management of Posterior Reversible Encephalopathy Syndrome Induced by Carfilzomib in a Patient With Multiple Myeloma.

J Clin Oncol 2016 Jan 5;34(2):e1-5. Epub 2014 May 5.

Brigham and Women's Hospital; and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.6166DOI Listing
January 2016

Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of FDG-PET/CT Findings With Clinical Outcome.

Clin Nucl Med 2016 Jan;41(1):e7-13

From the *Department of Imaging, Dana-Farber Cancer Institute, †Department of Radiology, Brigham and Women's Hospital, and ‡Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000000902DOI Listing
January 2016

Solitary Extramedullary Multiple Myeloma Presenting with Small Bowel Obstruction.

J Emerg Med 2016 Jan 4;50(1):e25-7. Epub 2015 Oct 4.

Department of Hematologic Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jemermed.2015.05.045DOI Listing
January 2016

CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.

PLoS One 2014 27;9(5):e97566. Epub 2014 May 27.

Harvard Medical School, Boston, Massachusetts, United States of America; Surgery Service, VA Boston Healthcare System, West Roxbury, Massachusetts, United States of America; Brigham and Women's Hospital, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0097566PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035256PMC
December 2015

Association of Agent Orange With Plasma Cell Disorder: Further Evidence.

Authors:
Nikhil C Munshi

JAMA Oncol 2015 Nov;1(8):1035-6

VA Boston Healthcare System, Boston, Massachusetts2Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.3015DOI Listing
November 2015

Pathogenesis beyond the cancer clone(s) in multiple myeloma.

Blood 2015 May 2;125(20):3049-58. Epub 2015 Apr 2.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Veterans Affairs Boston Healthcare System, West Roxbury, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-11-568881DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432002PMC
May 2015

Genomic heterogeneity in multiple myeloma.

Curr Opin Genet Dev 2015 02 16;30:56-65. Epub 2015 May 16.

Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States; VA Boston Healthcare System, Boston, MA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gde.2015.03.008DOI Listing
February 2015

Heteroclitic XBP1 peptides evoke tumor-specific memory cytotoxic T lymphocytes against breast cancer, colon cancer, and pancreatic cancer cells.

Oncoimmunology 2014;3(12):e970914. Epub 2014 Dec 2.

Dana-Farber Cancer Institute ; Boston, MA USA ; Harvard Medical School ; Boston, MA USA ; VA Boston Healthcare System ; Boston, MA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/21624011.2014.970914DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356023PMC
December 2014

Early or delayed transplantation for multiple myeloma in the era of novel therapy: does one size fit all?

Hematology Am Soc Hematol Educ Program 2014 Dec 18;2014(1):255-61. Epub 2014 Nov 18.

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2014.1.255DOI Listing
December 2014

Differential and limited expression of mutant alleles in multiple myeloma.

Blood 2014 Nov 18;124(20):3110-7. Epub 2014 Sep 18.

Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Hematology/Oncology, Boston Veterans Administration Healthcare System, West Roxbury, MA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-04-569327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231420PMC
November 2014

Immunotherapy strategies in multiple myeloma.

Hematol Oncol Clin North Am 2014 Oct;28(5):927-43

Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2014.07.002DOI Listing
October 2014

Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapy.

Clin Cancer Res 2014 Aug 23;20(15):3955-61. Epub 2014 Jun 23.

Massachusetts General Hospital Cancer Center; Harvard Medical School, Boston, Massachusetts

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0434DOI Listing
August 2014

MRI features of extramedullary myeloma.

AJR Am J Roentgenol 2014 Apr;202(4):803-10

1 Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.13.10856DOI Listing
April 2014

Immunotherapy for multiple myeloma.

Expert Rev Hematol 2014 Feb 13;7(1):91-6. Epub 2014 Jan 13.

Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2014.878226DOI Listing
February 2014

Reply to M. Roschewski et al.

J Clin Oncol 2014 Feb 13;32(5):478. Epub 2014 Jan 13.

VA Boston Healthcare System; and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.0998DOI Listing
February 2014

Biology of telomeres: importance in etiology of esophageal cancer and as therapeutic target.

Transl Res 2013 Dec 1;162(6):364-70. Epub 2013 Oct 1.

Harvard (Dana Farber) Cancer Institute, Boston, Mass; VA Boston Healthcare System, Boston, Mass.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trsl.2013.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834232PMC
December 2013

The shaping and functional consequences of the dosage effect landscape in multiple myeloma.

BMC Genomics 2013 Oct 2;14:672. Epub 2013 Oct 2.

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-14-672DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907079PMC
October 2013

Individualized therapy in multiple myeloma: are we there?

Semin Oncol 2013 Oct;40(5):567-76

Boston Veterans Affairs Healthcare System, Boston, MA; Boston Medical Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2013.08.001DOI Listing
October 2013

Phase transitions in human IgG solutions.

J Chem Phys 2013 Sep;139(12):121904

Materials Processing Center, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1063/1.4811345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108626PMC
September 2013

Signatures of mutational processes in human cancer.

Nature 2013 Aug 14;500(7463):415-21. Epub 2013 Aug 14.

Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature12477DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776390PMC
August 2013

New strategies in the treatment of multiple myeloma.

Clin Cancer Res 2013 Jul 20;19(13):3337-44. Epub 2013 Mar 20.

Veterans Administration Boston Healthcare System, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-12-1881DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112820PMC
July 2013

Minimal residual disease in multiple myeloma.

J Clin Oncol 2013 Jul 3;31(20):2523-6. Epub 2013 Jun 3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.2124DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321086PMC
July 2013

Proceedings of the Seventh International Workshop on Waldenström Macroglobulinemia.

Clin Lymphoma Myeloma Leuk 2013 Apr;13(2):181-3

Bing Center for Waldenström's Macroglobulinemia, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.04.001DOI Listing
April 2013